Arbutus Biopharma Corp
ABUSNasdaqCIK 1447028HealthcareFiscal year ends Dec 31
Reports and events: 558 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-05-2206:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-24-003042 |
| 2024-05-1709:03 ET | SC 13D/A | Ownership report, active investor, amended | 0001193805-24-000672 |
| 2024-05-0908:00 ET | SC 13D | Ownership report, active investor | 0001193805-24-000619 |
| 2024-05-0216:32 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001447028-24-000038 |
| 2024-05-0207:31 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-24-002453 |
| 2024-05-0207:26 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-24-002452 |
| 2024-04-1016:05 ET | DEF 14A | Proxy statementPeriod 2024-05-22 | 0001140361-24-019091 |
| 2024-04-0408:31 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-24-001830 |
| 2024-03-0516:48 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001447028-24-000035 |
| 2024-02-2907:31 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-24-001068 |
| 2024-01-0807:31 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-24-000113 |
| 2024-01-0416:09 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001447028-24-000006 |
| 2023-11-0916:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-23-006951 |
| 2023-11-0716:18 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001447028-23-000090 |
| 2023-11-0707:31 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-23-006796 |
| 2023-11-0707:16 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001171843-23-006795 |
| 2023-10-1108:06 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-23-006206 |
| 2023-09-1116:16 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-23-005658 |
| 2023-08-0316:10 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001447028-23-000082 |
| 2023-08-0307:31 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-23-004945 |
| 2023-07-1207:31 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001171843-23-004458 |
| 2023-07-1016:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-23-004433 |
| 2023-06-2107:31 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-23-004029 |
| 2023-06-2106:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-23-004026 |
| 2023-06-0706:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-23-003807 |
| 2023-05-3016:23 ET | 8-K | 5.07 Shareholder vote results | 0001447028-23-000052 |
| 2023-05-0416:07 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001447028-23-000025 |
| 2023-05-0407:32 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-23-002864 |
| 2023-04-2706:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-23-002604 |
| 2023-04-2507:31 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-23-002498 |
| 2023-04-1816:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-23-002368 |
| 2023-04-1216:05 ET | DEF 14A | Proxy statementPeriod 2023-05-24 | 0001140361-23-017990 |
| 2023-04-0408:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-23-002106 |
| 2023-03-1607:31 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-23-001710 |
| 2023-03-1416:06 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-23-001679 |
| 2023-03-0216:27 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001447028-23-000018 |
| 2023-03-0207:31 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-23-001339 |
| 2023-01-2707:31 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001171843-23-000518 |
| 2023-01-0507:31 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-23-000071 |
| 2022-12-1307:31 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-22-008011 |
| 2022-11-0916:10 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001447028-22-000055 |
| 2022-11-0907:31 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-22-007260 |
| 2022-11-0409:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-22-007106 |
| 2022-11-0116:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-22-006961 |
| 2022-10-3116:19 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-22-006904 |
| 2022-10-2407:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001447028-22-000051 |
| 2022-09-3009:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-22-006328 |
| 2022-08-3007:32 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-22-005860 |
| 2022-08-0416:08 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001447028-22-000047 |
| 2022-08-0407:32 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-22-005343 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 17:27 ET. Listed shows no prices and gives no investment advice.